Value of a national administrative database to guide public decisions: From the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France

In 1999, French legislators asked health insurance funds to develop a système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) [national health insurance information system] in order to more precisely determine and evaluate health care utilization and health care expenditure of b...

Full description

Saved in:
Bibliographic Details
Published inRevue d'épidémiologie et de santé publique Vol. 65; pp. S149 - S167
Main Authors Tuppin, P., Rudant, J., Constantinou, P., Gastaldi-Ménager, C., Rachas, A., de Roquefeuil, L., Maura, G., Caillol, H., Tajahmady, A., Coste, J., Gissot, C., Weill, A., Fagot-Campagna, A.
Format Journal Article
LanguageEnglish
Published France Elsevier Masson SAS 01.10.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In 1999, French legislators asked health insurance funds to develop a système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) [national health insurance information system] in order to more precisely determine and evaluate health care utilization and health care expenditure of beneficiaries. These data, based on almost 66 million inhabitants in 2015, have already been the subject of numerous international publications on various topics: prevalence and incidence of diseases, patient care pathways, health status and health care utilization of specific populations, real-life use of drugs, assessment of adverse effects of drugs or other health care procedures, monitoring of national health insurance expenditure, etc. SNIIRAM comprises individual information on the sociodemographic and medical characteristics of beneficiaries and all hospital care and office medicine reimbursements, coded according to various systems. Access to data is controlled by permissions dependent on the type of data requested or used, their temporality and the researcher's status. In general, data can be analyzed by accredited agencies over a period covering the last three years plus the current year, and specific requests can be submitted to extract data over longer periods. A 1/97th random sample of SNIIRAM, the échantillon généraliste des bénéficiaires (EGB), representative of the national population of health insurance beneficiaries, was composed in 2005 to allow 20-year follow-up with facilitated access for medical research. The EGB is an open cohort, which includes new beneficiaries and newborn infants. SNIIRAM has continued to grow and extend to become, in 2016, the cornerstone of the future système national des données de santé (SNDS) [national health data system], which will gradually integrate new information (causes of death, social and medical data and complementary health insurance). In parallel, the modalities of data access and protection systems have also evolved. This article describes the SNIIRAM data warehouse and its transformation into SNDS, the data collected, the tools developed in order to facilitate data analysis, the limitations encountered, and changing access permissions. En France, le législateur a souhaité en 1999 que les régimes d’Assurance Maladie développent un système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) afin de mieux connaître et évaluer le recours aux soins et les dépenses de santé des assurés. Ces données sur près de 66 millions d’habitants en 2015 ont déjà donné lieu à de nombreuses publications internationales s’intéressant à différentes thématiques : prévalence et incidence de pathologies, parcours de soins de patients, état de santé et recours aux soins de populations spécifiques, usage des médicaments en vie réelle, mesure d’effet indésirables de médicaments ou d’autres procédures de soins, suivi des dépenses de l’Assurance Maladie, etc. Le SNIIRAM contient des informations individuelles sur des caractéristiques sociodémographiques et médicales des assurés et l’ensemble des remboursements de soins hospitaliers et de médecine de ville, codés selon différents référentiels. L’accès aux données est soumis à des autorisations qui sont fonction de la nature des données demandées ou utilisées, de leur temporalité et du statut du demandeur. De façon générale, les données peuvent être analysées par les organismes habilités sur la période couvrant les trois dernières années plus l’année en cours, et des demandes spécifiques peuvent être réalisées pour extraire des données portant sur des historiques plus longs. Un échantillon généraliste de bénéficiaires (EGB) au 1/97e, représentatif de la population protégée au niveau national, a été constitué en 2005 pour permettre un suivi sur 20 ans avec un accès facilité pour la recherche médicale. Il s’agit d’une cohorte ouverte, qui inclut les nouveaux affiliés et nouveau-nés. Le SNIIRAM a continué à évoluer mais aussi à s’étendre pour devenir, en 2016, le socle du futur système national des données de santé (SNDS) qui intègrera progressivement de nouvelles informations (causes de décès, données médicosociales et des assurances complémentaires santé). Conjointement, les modalités d’accès aux données et les systèmes de protection évoluent aussi. Cet article a pour but de décrire le SNIIRAM et l’évolution vers le SNDS, les données recueillies, les outils développés afin d’en faciliter l’analyse, les limites rencontrées, les autorisations d’accès et leurs évolutions.
AbstractList In 1999, French legislators asked health insurance funds to develop a système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) [national health insurance information system] in order to more precisely determine and evaluate health care utilization and health care expenditure of beneficiaries. These data, based on almost 66 million inhabitants in 2015, have already been the subject of numerous international publications on various topics: prevalence and incidence of diseases, patient care pathways, health status and health care utilization of specific populations, real-life use of drugs, assessment of adverse effects of drugs or other health care procedures, monitoring of national health insurance expenditure, etc. SNIIRAM comprises individual information on the sociodemographic and medical characteristics of beneficiaries and all hospital care and office medicine reimbursements, coded according to various systems. Access to data is controlled by permissions dependent on the type of data requested or used, their temporality and the researcher's status. In general, data can be analyzed by accredited agencies over a period covering the last three years plus the current year, and specific requests can be submitted to extract data over longer periods. A 1/97th random sample of SNIIRAM, the échantillon généraliste des bénéficiaires (EGB), representative of the national population of health insurance beneficiaries, was composed in 2005 to allow 20-year follow-up with facilitated access for medical research. The EGB is an open cohort, which includes new beneficiaries and newborn infants. SNIIRAM has continued to grow and extend to become, in 2016, the cornerstone of the future système national des données de santé (SNDS) [national health data system], which will gradually integrate new information (causes of death, social and medical data and complementary health insurance). In parallel, the modalities of data access and protection systems have also evolved. This article describes the SNIIRAM data warehouse and its transformation into SNDS, the data collected, the tools developed in order to facilitate data analysis, the limitations encountered, and changing access permissions. En France, le législateur a souhaité en 1999 que les régimes d’Assurance Maladie développent un système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) afin de mieux connaître et évaluer le recours aux soins et les dépenses de santé des assurés. Ces données sur près de 66 millions d’habitants en 2015 ont déjà donné lieu à de nombreuses publications internationales s’intéressant à différentes thématiques : prévalence et incidence de pathologies, parcours de soins de patients, état de santé et recours aux soins de populations spécifiques, usage des médicaments en vie réelle, mesure d’effet indésirables de médicaments ou d’autres procédures de soins, suivi des dépenses de l’Assurance Maladie, etc. Le SNIIRAM contient des informations individuelles sur des caractéristiques sociodémographiques et médicales des assurés et l’ensemble des remboursements de soins hospitaliers et de médecine de ville, codés selon différents référentiels. L’accès aux données est soumis à des autorisations qui sont fonction de la nature des données demandées ou utilisées, de leur temporalité et du statut du demandeur. De façon générale, les données peuvent être analysées par les organismes habilités sur la période couvrant les trois dernières années plus l’année en cours, et des demandes spécifiques peuvent être réalisées pour extraire des données portant sur des historiques plus longs. Un échantillon généraliste de bénéficiaires (EGB) au 1/97e, représentatif de la population protégée au niveau national, a été constitué en 2005 pour permettre un suivi sur 20 ans avec un accès facilité pour la recherche médicale. Il s’agit d’une cohorte ouverte, qui inclut les nouveaux affiliés et nouveau-nés. Le SNIIRAM a continué à évoluer mais aussi à s’étendre pour devenir, en 2016, le socle du futur système national des données de santé (SNDS) qui intègrera progressivement de nouvelles informations (causes de décès, données médicosociales et des assurances complémentaires santé). Conjointement, les modalités d’accès aux données et les systèmes de protection évoluent aussi. Cet article a pour but de décrire le SNIIRAM et l’évolution vers le SNDS, les données recueillies, les outils développés afin d’en faciliter l’analyse, les limites rencontrées, les autorisations d’accès et leurs évolutions.
In 1999, French legislators asked health insurance funds to develop a système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) [national health insurance information system] in order to more precisely determine and evaluate health care utilization and health care expenditure of beneficiaries. These data, based on almost 66 million inhabitants in 2015, have already been the subject of numerous international publications on various topics: prevalence and incidence of diseases, patient care pathways, health status and health care utilization of specific populations, real-life use of drugs, assessment of adverse effects of drugs or other health care procedures, monitoring of national health insurance expenditure, etc. SNIIRAM comprises individual information on the sociodemographic and medical characteristics of beneficiaries and all hospital care and office medicine reimbursements, coded according to various systems. Access to data is controlled by permissions dependent on the type of data requested or used, their temporality and the researcher's status. In general, data can be analyzed by accredited agencies over a period covering the last three years plus the current year, and specific requests can be submitted to extract data over longer periods. A 1/97th random sample of SNIIRAM, the échantillon généraliste des bénéficiaires (EGB), representative of the national population of health insurance beneficiaries, was composed in 2005 to allow 20-year follow-up with facilitated access for medical research. The EGB is an open cohort, which includes new beneficiaries and newborn infants. SNIIRAM has continued to grow and extend to become, in 2016, the cornerstone of the future système national des données de santé (SNDS) [national health data system], which will gradually integrate new information (causes of death, social and medical data and complementary health insurance). In parallel, the modalities of data access and protection systems have also evolved. This article describes the SNIIRAM data warehouse and its transformation into SNDS, the data collected, the tools developed in order to facilitate data analysis, the limitations encountered, and changing access permissions.
In 1999, French legislators asked health insurance funds to develop a système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) [national health insurance information system] in order to more precisely determine and evaluate health care utilization and health care expenditure of beneficiaries. These data, based on almost 66 million inhabitants in 2015, have already been the subject of numerous international publications on various topics: prevalence and incidence of diseases, patient care pathways, health status and health care utilization of specific populations, real-life use of drugs, assessment of adverse effects of drugs or other health care procedures, monitoring of national health insurance expenditure, etc. SNIIRAM comprises individual information on the sociodemographic and medical characteristics of beneficiaries and all hospital care and office medicine reimbursements, coded according to various systems. Access to data is controlled by permissions dependent on the type of data requested or used, their temporality and the researcher's status. In general, data can be analyzed by accredited agencies over a period covering the last three years plus the current year, and specific requests can be submitted to extract data over longer periods. A 1/97th random sample of SNIIRAM, the échantillon généraliste des bénéficiaires (EGB), representative of the national population of health insurance beneficiaries, was composed in 2005 to allow 20-year follow-up with facilitated access for medical research. The EGB is an open cohort, which includes new beneficiaries and newborn infants. SNIIRAM has continued to grow and extend to become, in 2016, the cornerstone of the future système national des données de santé (SNDS) [national health data system], which will gradually integrate new information (causes of death, social and medical data and complementary health insurance). In parallel, the modalities of data access and protection systems have also evolved. This article describes the SNIIRAM data warehouse and its transformation into SNDS, the data collected, the tools developed in order to facilitate data analysis, the limitations encountered, and changing access permissions.In 1999, French legislators asked health insurance funds to develop a système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) [national health insurance information system] in order to more precisely determine and evaluate health care utilization and health care expenditure of beneficiaries. These data, based on almost 66 million inhabitants in 2015, have already been the subject of numerous international publications on various topics: prevalence and incidence of diseases, patient care pathways, health status and health care utilization of specific populations, real-life use of drugs, assessment of adverse effects of drugs or other health care procedures, monitoring of national health insurance expenditure, etc. SNIIRAM comprises individual information on the sociodemographic and medical characteristics of beneficiaries and all hospital care and office medicine reimbursements, coded according to various systems. Access to data is controlled by permissions dependent on the type of data requested or used, their temporality and the researcher's status. In general, data can be analyzed by accredited agencies over a period covering the last three years plus the current year, and specific requests can be submitted to extract data over longer periods. A 1/97th random sample of SNIIRAM, the échantillon généraliste des bénéficiaires (EGB), representative of the national population of health insurance beneficiaries, was composed in 2005 to allow 20-year follow-up with facilitated access for medical research. The EGB is an open cohort, which includes new beneficiaries and newborn infants. SNIIRAM has continued to grow and extend to become, in 2016, the cornerstone of the future système national des données de santé (SNDS) [national health data system], which will gradually integrate new information (causes of death, social and medical data and complementary health insurance). In parallel, the modalities of data access and protection systems have also evolved. This article describes the SNIIRAM data warehouse and its transformation into SNDS, the data collected, the tools developed in order to facilitate data analysis, the limitations encountered, and changing access permissions.
Author Gissot, C.
Weill, A.
Constantinou, P.
Tajahmady, A.
Caillol, H.
Tuppin, P.
Rudant, J.
de Roquefeuil, L.
Gastaldi-Ménager, C.
Rachas, A.
Fagot-Campagna, A.
Coste, J.
Maura, G.
Author_xml – sequence: 1
  givenname: P.
  orcidid: 0000-0001-5698-9215
  surname: Tuppin
  fullname: Tuppin, P.
  email: philippe.tuppin@cnamts.fr
– sequence: 2
  givenname: J.
  surname: Rudant
  fullname: Rudant, J.
– sequence: 3
  givenname: P.
  surname: Constantinou
  fullname: Constantinou, P.
– sequence: 4
  givenname: C.
  surname: Gastaldi-Ménager
  fullname: Gastaldi-Ménager, C.
– sequence: 5
  givenname: A.
  surname: Rachas
  fullname: Rachas, A.
– sequence: 6
  givenname: L.
  surname: de Roquefeuil
  fullname: de Roquefeuil, L.
– sequence: 7
  givenname: G.
  surname: Maura
  fullname: Maura, G.
– sequence: 8
  givenname: H.
  surname: Caillol
  fullname: Caillol, H.
– sequence: 9
  givenname: A.
  surname: Tajahmady
  fullname: Tajahmady, A.
– sequence: 10
  givenname: J.
  surname: Coste
  fullname: Coste, J.
– sequence: 11
  givenname: C.
  surname: Gissot
  fullname: Gissot, C.
– sequence: 12
  givenname: A.
  surname: Weill
  fullname: Weill, A.
– sequence: 13
  givenname: A.
  surname: Fagot-Campagna
  fullname: Fagot-Campagna, A.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28756037$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1u1DAYhr0ooj9wAiTkZbuYYCdxEiOxGBUKI7UgUWBrOfHn4lFiD7ZTqTuu0Rt0zjE3gYvgzLRCQqIrS5_e57H9vYdozzoLCL2gJKOEVq-WmYewgiwntM4Iywgp99ABKXgzq6uc7KPDEJaEkLwu66doP29qVpGiPkC_v8l-BOw0ltjKaJyVPZZqMNaE6NPgGrCSUbYyAI4OX41GAV6NbW86rKAzISHhNT7zbsDxO-BwE-LmboC_NvXr562x2vlhO8HGRvB-s74yA4TkwH0KzEMYvbQd4AvZS2UAH19-XCw-zy9Opmv_Y554Z-1mvRMFaeNmPZFvL0_SPelVk_IZeqJlH-D5_XmEvp69-3L6YXb-6f3idH4-6wrG40w3PK-0ZlLzinJOdU2pKimDnOVFIzvKiNS0qSRA2WpgijeVVnlbVIyRspHFETreeVfe_RghRDGY0EHfSwtuDILyvGx4ijYp-vI-OrYDKLHyZpD-RjwUkwJ8F-i8C8GDFp2J23-nVkwvKBFT8WIptsWLqXhBmEjFJ7b4h33QP0692VGQVnRtwIvQGUjrU8ZDF4Vy5lH-D3hM00M
CitedBy_id crossref_primary_10_1002_jbm4_10507
crossref_primary_10_2196_57584
crossref_primary_10_1097_YIC_0000000000000312
crossref_primary_10_1097_MD_0000000000034555
crossref_primary_10_3390_ijerph17124301
crossref_primary_10_1016_j_jacc_2024_02_003
crossref_primary_10_1016_S1769_7255_22_00572_7
crossref_primary_10_1016_j_rcot_2021_04_002
crossref_primary_10_1111_dme_14820
crossref_primary_10_1001_jamaneurol_2023_2968
crossref_primary_10_1177_14604582241259336
crossref_primary_10_1002_cam4_3074
crossref_primary_10_1016_j_clbc_2021_01_007
crossref_primary_10_1016_j_jid_2020_07_038
crossref_primary_10_1016_j_diabet_2025_101638
crossref_primary_10_2196_62939
crossref_primary_10_1111_jne_13092
crossref_primary_10_3390_cancers13020308
crossref_primary_10_1002_ehf2_14072
crossref_primary_10_12968_jowc_2023_32_10_615
crossref_primary_10_3390_jcm11061669
crossref_primary_10_3390_vaccines10111938
crossref_primary_10_1007_s40266_023_01085_7
crossref_primary_10_1038_s41380_023_02175_z
crossref_primary_10_1016_S2468_2667_22_00106_2
crossref_primary_10_1016_j_therap_2023_02_001
crossref_primary_10_1016_j_jeph_2024_202786
crossref_primary_10_1016_j_respe_2019_11_018
crossref_primary_10_1186_s13054_022_04212_9
crossref_primary_10_3390_jcm12020412
crossref_primary_10_1111_bcp_15543
crossref_primary_10_1111_bjd_20659
crossref_primary_10_1111_jch_14055
crossref_primary_10_3389_fpsyt_2021_640120
crossref_primary_10_1002_jia2_25986
crossref_primary_10_1016_j_hpb_2024_10_011
crossref_primary_10_1183_13993003_03130_2021
crossref_primary_10_1016_j_jval_2021_05_004
crossref_primary_10_1016_j_neurol_2021_06_009
crossref_primary_10_1007_s10549_022_06626_z
crossref_primary_10_12968_jowc_2024_0189
crossref_primary_10_1007_s40259_024_00699_6
crossref_primary_10_3390_jcm9040920
crossref_primary_10_1038_s41598_023_49102_4
crossref_primary_10_1016_j_acvd_2020_05_009
crossref_primary_10_1111_jth_14205
crossref_primary_10_1136_bmjopen_2018_025810
crossref_primary_10_1016_j_therap_2017_12_008
crossref_primary_10_1093_ndt_gfae042
crossref_primary_10_1111_epi_17906
crossref_primary_10_1016_j_ejvs_2023_11_001
crossref_primary_10_1016_j_diabet_2025_101615
crossref_primary_10_1016_j_amcp_2019_02_004
crossref_primary_10_1177_1758835920967237
crossref_primary_10_1556_650_2021_32151
crossref_primary_10_1088_1361_6579_ac2a8f
crossref_primary_10_1007_s00330_022_08602_z
crossref_primary_10_1007_s10198_021_01363_4
crossref_primary_10_1111_apt_16448
crossref_primary_10_1136_rmdopen_2023_003865
crossref_primary_10_1002_ehf2_15137
crossref_primary_10_1186_s13058_023_01623_6
crossref_primary_10_1007_s10198_023_01585_8
crossref_primary_10_1016_j_jjcc_2023_07_010
crossref_primary_10_1016_j_acvd_2024_05_120
crossref_primary_10_1186_s12883_024_03797_8
crossref_primary_10_1186_s12913_023_09861_2
crossref_primary_10_1016_j_ijmedinf_2020_104203
crossref_primary_10_1002_jbm4_10789
crossref_primary_10_1111_bcp_15638
crossref_primary_10_3389_fcvm_2022_856689
crossref_primary_10_1002_clc_23231
crossref_primary_10_1016_j_canep_2024_102679
crossref_primary_10_1051_medsci_2019134
crossref_primary_10_2196_45030
crossref_primary_10_1016_j_wneu_2020_10_012
crossref_primary_10_1186_s12888_017_1555_0
crossref_primary_10_1080_03007995_2021_1944075
crossref_primary_10_1097_HPC_0000000000000199
crossref_primary_10_1016_j_jpsychires_2022_12_030
crossref_primary_10_3389_fped_2021_666848
crossref_primary_10_1186_s12877_024_04946_x
crossref_primary_10_1371_journal_pmed_1004134
crossref_primary_10_1016_j_otsr_2023_103575
crossref_primary_10_1038_s41598_022_17224_w
crossref_primary_10_1016_j_diabet_2024_101564
crossref_primary_10_1093_jnci_djac019
crossref_primary_10_1371_journal_pone_0302205
crossref_primary_10_1002_jimd_12822
crossref_primary_10_1016_j_arcped_2022_11_014
crossref_primary_10_1177_02692163211019299
crossref_primary_10_2105_AJPH_2020_305781
crossref_primary_10_1111_bcp_14415
crossref_primary_10_1038_s41598_023_43790_8
crossref_primary_10_1001_jamanetworkopen_2023_42006
crossref_primary_10_1136_bmjopen_2019_034829
crossref_primary_10_1111_jch_14254
crossref_primary_10_3389_fpsyt_2022_1021780
crossref_primary_10_1016_j_drugalcdep_2021_108748
crossref_primary_10_1016_j_atmosenv_2021_118668
crossref_primary_10_1186_s12889_025_22118_3
crossref_primary_10_3390_jcm10112367
crossref_primary_10_1177_1756284819853790
crossref_primary_10_1016_j_canep_2020_101875
crossref_primary_10_14245_ns_2143186_593
crossref_primary_10_1016_j_nephro_2018_03_004
crossref_primary_10_1016_j_eclinm_2020_100445
crossref_primary_10_1001_jamadermatol_2022_0364
crossref_primary_10_3917_spub_223_0345
crossref_primary_10_2196_56398
crossref_primary_10_1111_add_16261
crossref_primary_10_1371_journal_pone_0245392
crossref_primary_10_1016_j_therap_2023_01_009
crossref_primary_10_1016_j_dld_2024_07_030
crossref_primary_10_1080_13811118_2020_1735596
crossref_primary_10_1136_rmdopen_2022_002681
crossref_primary_10_1080_13696998_2019_1590841
crossref_primary_10_1016_j_therap_2023_01_010
crossref_primary_10_1371_journal_pone_0214649
crossref_primary_10_1038_s41598_022_22689_w
crossref_primary_10_1111_apt_15323
crossref_primary_10_1111_apt_16410
crossref_primary_10_1016_j_chest_2020_06_055
crossref_primary_10_1186_s12913_020_05173_x
crossref_primary_10_1007_s40264_023_01336_x
crossref_primary_10_1016_j_drugpo_2019_05_013
crossref_primary_10_1016_j_bulcan_2019_11_011
crossref_primary_10_1016_j_diabres_2020_108252
crossref_primary_10_1210_clinem_dgaa838
crossref_primary_10_1111_ene_14831
crossref_primary_10_1016_j_lpm_2019_09_044
crossref_primary_10_1016_S1957_2557_18_30047_6
crossref_primary_10_1007_s10198_022_01513_2
crossref_primary_10_1016_j_semarthrit_2020_09_001
crossref_primary_10_1136_rmdopen_2021_002139
crossref_primary_10_1111_jdv_20073
crossref_primary_10_1186_s13018_023_03893_4
crossref_primary_10_1016_j_respe_2021_01_008
crossref_primary_10_1186_s12879_020_05478_6
crossref_primary_10_1016_j_cmi_2024_08_012
crossref_primary_10_14791_btrt_2021_9_e9
crossref_primary_10_1016_j_otsr_2023_103667
crossref_primary_10_1111_1471_0528_16670
crossref_primary_10_1212_CPJ_0000000000000717
crossref_primary_10_1186_s12931_023_02393_7
crossref_primary_10_3389_fpsyt_2022_893590
crossref_primary_10_1016_j_cgh_2023_06_025
crossref_primary_10_1111_liv_15872
crossref_primary_10_1111_bjd_18047
crossref_primary_10_1371_journal_pone_0277135
crossref_primary_10_1080_14737167_2021_1981863
crossref_primary_10_1182_bloodadvances_2023009801
crossref_primary_10_1001_jamanetworkopen_2023_15235
crossref_primary_10_1186_s12886_023_03134_6
crossref_primary_10_1371_journal_pone_0267317
crossref_primary_10_1007_s10803_024_06519_8
crossref_primary_10_1016_j_respe_2017_01_118
crossref_primary_10_1016_j_therap_2017_11_008
crossref_primary_10_1016_j_jbi_2020_103531
crossref_primary_10_1016_j_jclinepi_2018_07_003
crossref_primary_10_1016_j_ejvs_2024_01_091
crossref_primary_10_1016_j_otsr_2021_103090
crossref_primary_10_1093_eurheartj_ehz458
crossref_primary_10_1007_s00228_023_03501_8
crossref_primary_10_1093_ced_llae553
crossref_primary_10_1161_JAHA_120_017588
crossref_primary_10_1016_j_acvd_2019_11_011
crossref_primary_10_1016_j_jamda_2020_02_019
crossref_primary_10_1111_jvh_13788
crossref_primary_10_1016_j_rhum_2024_05_008
crossref_primary_10_2196_41048
crossref_primary_10_1161_STROKEAHA_120_028825
crossref_primary_10_1186_s13561_023_00464_5
crossref_primary_10_1186_s12933_023_02101_1
crossref_primary_10_1016_S1634_7072_23_48431_0
crossref_primary_10_2807_1560_7917_ES_2021_26_34_2001466
crossref_primary_10_1016_j_nephro_2017_11_006
crossref_primary_10_1016_j_accpm_2019_02_007
crossref_primary_10_1212_WNL_0000000000209662
crossref_primary_10_1016_j_neurol_2023_12_007
crossref_primary_10_1016_j_neurol_2021_04_006
crossref_primary_10_3389_fcvm_2024_1458410
crossref_primary_10_2196_50085
crossref_primary_10_1016_j_acvd_2022_06_006
crossref_primary_10_1016_j_healthpol_2022_06_007
crossref_primary_10_1007_s00277_024_05859_w
crossref_primary_10_1016_j_puhe_2023_12_022
crossref_primary_10_1016_j_msard_2025_106305
crossref_primary_10_1177_14604582211033020
crossref_primary_10_1016_j_therap_2018_09_078
crossref_primary_10_2196_29286
crossref_primary_10_1016_j_therap_2018_09_076
crossref_primary_10_1111_jdv_19447
crossref_primary_10_1186_s12905_023_02784_4
crossref_primary_10_1080_13696998_2020_1715415
crossref_primary_10_1016_j_purol_2019_09_006
crossref_primary_10_1016_j_canep_2022_102270
crossref_primary_10_3389_fpubh_2022_1043691
crossref_primary_10_1001_jamanetworkopen_2024_41874
crossref_primary_10_1007_s10198_018_1024_9
crossref_primary_10_1542_peds_2017_3783
crossref_primary_10_1093_rheumatology_kead293
crossref_primary_10_1016_j_rcot_2023_07_022
crossref_primary_10_1177_2055217320941540
crossref_primary_10_3390_ijerph16245010
crossref_primary_10_3389_fmed_2024_1494713
crossref_primary_10_1164_rccm_202105_1274OC
crossref_primary_10_1093_ije_dyz093
crossref_primary_10_1136_bmjopen_2020_044891
crossref_primary_10_1111_add_14820
crossref_primary_10_1016_j_thromres_2021_09_009
crossref_primary_10_14791_btrt_2024_0020
crossref_primary_10_1183_23120541_00109_2024
crossref_primary_10_1007_s10654_019_00594_3
crossref_primary_10_1038_s41598_020_74409_x
crossref_primary_10_2147_CLEP_S385555
crossref_primary_10_1016_j_vaccine_2021_07_054
crossref_primary_10_3390_jcm13196019
crossref_primary_10_1002_pds_5170
crossref_primary_10_1136_bmjopen_2018_026645
crossref_primary_10_1080_20476965_2019_1581433
crossref_primary_10_1016_j_jcf_2021_03_025
crossref_primary_10_1093_humrep_deab147
crossref_primary_10_1161_STROKEAHA_123_045632
crossref_primary_10_1016_j_otsr_2021_102923
crossref_primary_10_3389_fpubh_2022_823193
crossref_primary_10_1016_j_diabres_2023_111007
crossref_primary_10_1016_j_ophtha_2022_12_022
crossref_primary_10_1001_jamanetworkopen_2024_52789
crossref_primary_10_1111_myc_13676
crossref_primary_10_1177_08982643221135318
crossref_primary_10_1212_WNL_0000000000009180
crossref_primary_10_1177_13524585211035376
crossref_primary_10_1177_2055217317730421
crossref_primary_10_1007_s10029_023_02825_9
crossref_primary_10_1016_j_jbspin_2022_105460
crossref_primary_10_1177_2055217319896090
crossref_primary_10_1097_MD_0000000000023445
crossref_primary_10_1016_j_esmoop_2024_104083
crossref_primary_10_1016_j_clinre_2023_102177
crossref_primary_10_3390_antibiotics11050643
crossref_primary_10_1111_aos_15799
crossref_primary_10_1016_j_esmorw_2024_100045
crossref_primary_10_1016_j_psychres_2024_116032
crossref_primary_10_2196_31136
crossref_primary_10_1016_j_bulcan_2024_12_007
crossref_primary_10_1186_s12889_021_11682_z
crossref_primary_10_1002_art_41923
crossref_primary_10_1007_s00737_020_01033_z
crossref_primary_10_1007_s40123_023_00772_3
crossref_primary_10_1016_j_vaccine_2020_12_021
crossref_primary_10_1136_bmjopen_2021_057943
crossref_primary_10_1371_journal_pdig_0000298
crossref_primary_10_1016_j_ekir_2020_10_026
crossref_primary_10_1212_WNL_0000000000209228
crossref_primary_10_1186_s12874_021_01285_y
crossref_primary_10_1016_j_clbc_2024_04_004
crossref_primary_10_1161_HYPERTENSIONAHA_124_23760
crossref_primary_10_1007_s10198_021_01304_1
crossref_primary_10_1007_s11060_020_03672_9
crossref_primary_10_1186_s10194_024_01770_x
crossref_primary_10_1007_s00228_020_02952_7
crossref_primary_10_1183_23120541_00976_2023
crossref_primary_10_1016_j_envint_2023_107999
crossref_primary_10_1097_MLR_0000000000001745
crossref_primary_10_1093_ije_dyaa048
crossref_primary_10_2217_fon_2021_1420
crossref_primary_10_1016_j_healthpol_2022_05_009
crossref_primary_10_3389_fpsyt_2022_923916
crossref_primary_10_1186_s12879_021_06287_1
crossref_primary_10_1007_s00415_024_12589_6
crossref_primary_10_1016_j_therap_2022_12_012
crossref_primary_10_1093_jac_dkab263
crossref_primary_10_1097_j_pain_0000000000002093
crossref_primary_10_1016_j_acvd_2020_04_006
crossref_primary_10_1016_j_diabet_2019_12_006
crossref_primary_10_1093_gerona_glad032
crossref_primary_10_1016_j_lanepe_2024_100921
crossref_primary_10_1016_j_jcv_2023_105635
crossref_primary_10_1111_jdv_16005
crossref_primary_10_1016_S2213_8587_19_30191_3
crossref_primary_10_1016_j_therap_2018_11_012
crossref_primary_10_1136_bmjopen_2018_025482
crossref_primary_10_1016_j_therap_2018_11_011
crossref_primary_10_1007_s40258_018_0451_1
crossref_primary_10_1016_j_ajogmf_2022_100781
crossref_primary_10_1080_02688697_2022_2159925
crossref_primary_10_1186_s12913_022_07725_9
crossref_primary_10_1007_s00270_022_03193_0
crossref_primary_10_1016_S2352_3026_24_00288_6
crossref_primary_10_1007_s10654_024_01125_5
crossref_primary_10_1371_journal_pmed_1003801
crossref_primary_10_1111_fcp_12696
crossref_primary_10_1002_pds_4556
crossref_primary_10_1016_j_cgh_2018_08_005
crossref_primary_10_1080_14737167_2021_1945926
crossref_primary_10_1016_j_jamda_2023_02_005
crossref_primary_10_1136_bmjopen_2023_075197
crossref_primary_10_1109_JBHI_2020_3021790
crossref_primary_10_1016_j_resmer_2023_101051
crossref_primary_10_1016_j_therap_2025_02_003
crossref_primary_10_1289_EHP8719
crossref_primary_10_1111_eci_13824
crossref_primary_10_12968_jowc_2023_32_Sup9a_clxxi
crossref_primary_10_1111_ppe_13178
crossref_primary_10_1016_j_yebeh_2021_108449
crossref_primary_10_1161_JAHA_121_023357
crossref_primary_10_46327_msrjg_1_000000000000262
crossref_primary_10_1186_s12889_022_13246_1
crossref_primary_10_1111_fcp_12341
crossref_primary_10_1371_journal_pone_0242524
crossref_primary_10_1002_art_41962
crossref_primary_10_1111_bjd_16809
crossref_primary_10_1093_cid_ciae610
crossref_primary_10_1200_JCO_24_01131
crossref_primary_10_1200_CCI_21_00108
crossref_primary_10_1007_s10198_022_01463_9
crossref_primary_10_1055_a_2180_9622
crossref_primary_10_1186_s12875_022_01792_x
crossref_primary_10_1002_cam4_2200
crossref_primary_10_1016_j_rmed_2024_107917
crossref_primary_10_1530_EJE_22_0355
crossref_primary_10_1111_bjd_20069
crossref_primary_10_1002_pds_5669
crossref_primary_10_1093_humrep_dead226
crossref_primary_10_1016_j_jogoh_2018_05_014
crossref_primary_10_1161_CIRCOUTCOMES_117_004356
crossref_primary_10_1002_hon_3062
crossref_primary_10_1186_s13690_021_00687_0
crossref_primary_10_1016_j_acvd_2021_11_002
crossref_primary_10_7326_M18_1512
crossref_primary_10_1093_ndt_gfaa229
crossref_primary_10_1002_ehf2_14725
crossref_primary_10_1186_s13063_020_04259_5
crossref_primary_10_1016_j_jclinepi_2023_01_002
crossref_primary_10_1016_j_clineuro_2020_106236
crossref_primary_10_2147_CLEP_S290707
crossref_primary_10_1186_s12913_022_07496_3
crossref_primary_10_1093_humrep_dead232
crossref_primary_10_1016_j_ajt_2023_10_017
crossref_primary_10_3390_ijerph17103367
crossref_primary_10_1016_j_cgh_2021_07_028
crossref_primary_10_1016_j_vaccine_2024_126252
crossref_primary_10_1371_journal_pone_0245854
crossref_primary_10_1164_rccm_202310_1771LE
crossref_primary_10_1016_j_amcp_2025_03_010
crossref_primary_10_1016_j_lanepe_2021_100281
crossref_primary_10_1186_s12931_021_01714_y
crossref_primary_10_1111_codi_15581
crossref_primary_10_1097_HJH_0000000000002875
crossref_primary_10_1111_jgs_19324
crossref_primary_10_1016_j_jinf_2021_02_001
crossref_primary_10_7326_M22_0819
crossref_primary_10_1016_j_acvd_2021_10_008
crossref_primary_10_1371_journal_pone_0285467
crossref_primary_10_1038_s41746_022_00647_0
crossref_primary_10_1093_ije_dyac152
crossref_primary_10_1111_bcp_15071
crossref_primary_10_1016_j_resmer_2021_100854
crossref_primary_10_1111_apt_16074
crossref_primary_10_1212_WNL_0000000000209885
crossref_primary_10_1016_j_lanepe_2021_100158
crossref_primary_10_1093_jamia_ocab237
crossref_primary_10_1136_archdischild_2024_327814
crossref_primary_10_1186_s12874_019_0745_5
crossref_primary_10_1007_s10198_024_01740_9
crossref_primary_10_1186_s12885_023_10877_4
crossref_primary_10_1016_j_idnow_2021_07_006
crossref_primary_10_1093_rheumatology_kez251
crossref_primary_10_1111_ene_15226
crossref_primary_10_1007_s12519_024_00873_4
crossref_primary_10_1111_ene_14256
crossref_primary_10_1007_s41030_024_00259_x
crossref_primary_10_1007_s10198_020_01229_1
crossref_primary_10_1038_s41598_024_65643_8
crossref_primary_10_1007_s00038_018_1186_3
crossref_primary_10_1093_bjd_ljac085
crossref_primary_10_1097_HS9_0000000000000412
crossref_primary_10_1016_j_deman_2022_100083
crossref_primary_10_1038_s41575_019_0102_5
crossref_primary_10_1007_s40258_020_00562_z
crossref_primary_10_1016_j_lanepe_2024_100901
crossref_primary_10_14309_ajg_0000000000000574
crossref_primary_10_1002_cam4_2527
crossref_primary_10_2147_CLEP_S340031
crossref_primary_10_1097_HJH_0000000000003989
crossref_primary_10_1136_rmdopen_2024_004631
crossref_primary_10_1002_jbmr_4720
crossref_primary_10_3389_fpubh_2023_1161550
crossref_primary_10_3917_popu_2303_0363
crossref_primary_10_1016_j_clinre_2024_102426
crossref_primary_10_1111_jch_13834
crossref_primary_10_3917_spub_191_0137
crossref_primary_10_1016_j_rcot_2021_09_127
crossref_primary_10_3390_ijerph19052962
crossref_primary_10_1186_s13613_024_01371_6
crossref_primary_10_1016_j_acvd_2022_11_002
crossref_primary_10_1093_eurpub_ckae223
crossref_primary_10_1177_20406223221108397
crossref_primary_10_1001_jamanetworkopen_2019_3215
crossref_primary_10_1182_blood_2021010848
crossref_primary_10_1002_art_42862
crossref_primary_10_1513_AnnalsATS_202009_1202OC
crossref_primary_10_1016_j_lanepe_2023_100717
crossref_primary_10_1038_s41467_024_47002_3
crossref_primary_10_1051_medsci_20183405018
crossref_primary_10_1016_j_acvd_2024_10_004
crossref_primary_10_1016_j_respe_2020_10_008
crossref_primary_10_1016_j_acvd_2024_10_003
crossref_primary_10_1016_j_neurol_2025_01_410
crossref_primary_10_1111_ene_15490
crossref_primary_10_1093_eurjpc_zwad288
crossref_primary_10_3389_fendo_2023_1193290
crossref_primary_10_1002_pds_5576
crossref_primary_10_1038_s41598_022_24050_7
crossref_primary_10_1136_bmj_n37
crossref_primary_10_1007_s00415_023_11953_2
crossref_primary_10_3389_fneur_2023_1129117
crossref_primary_10_1080_00913847_2024_2435256
crossref_primary_10_1111_aos_15143
crossref_primary_10_3389_ijph_2024_1606617
crossref_primary_10_1016_j_chest_2022_10_008
crossref_primary_10_1038_s41598_023_32356_3
crossref_primary_10_1016_j_wneu_2023_03_015
crossref_primary_10_1080_03007995_2024_2368197
crossref_primary_10_1021_acs_chemrestox_9b00529
crossref_primary_10_1016_j_xops_2022_100114
crossref_primary_10_1111_ene_16504
crossref_primary_10_1002_epi4_12636
crossref_primary_10_1111_fcp_12962
crossref_primary_10_1111_ppe_12816
crossref_primary_10_1001_jamadermatol_2021_2599
crossref_primary_10_1136_bmjmed_2021_000104
crossref_primary_10_1177_1073274820977175
crossref_primary_10_1186_s41927_024_00385_8
crossref_primary_10_1016_j_cardfail_2020_07_018
crossref_primary_10_1007_s40263_020_00736_2
crossref_primary_10_1016_j_euros_2023_05_013
crossref_primary_10_1007_s40259_023_00584_8
crossref_primary_10_1016_j_jhep_2024_01_030
crossref_primary_10_1016_j_acvd_2024_10_327
crossref_primary_10_3390_jcm11123289
crossref_primary_10_1016_j_acvd_2024_10_326
crossref_primary_10_1016_j_transproceed_2024_05_027
crossref_primary_10_1186_s12913_023_10145_y
crossref_primary_10_1210_jc_2018_00273
crossref_primary_10_1016_j_genhosppsych_2023_10_007
crossref_primary_10_1186_s12874_024_02447_4
crossref_primary_10_1111_ene_16518
crossref_primary_10_1016_j_mmifmc_2024_04_435
crossref_primary_10_1111_fcp_12612
crossref_primary_10_1111_jdv_19901
crossref_primary_10_1371_journal_pone_0299601
crossref_primary_10_14309_ctg_0000000000000773
crossref_primary_10_1093_ofid_ofac054
crossref_primary_10_1016_j_clbc_2022_05_006
crossref_primary_10_1016_j_jamda_2024_105459
crossref_primary_10_1186_s13098_023_01105_x
crossref_primary_10_1111_ejh_13976
crossref_primary_10_1016_j_eclinm_2024_103053
crossref_primary_10_3389_fonc_2021_675609
crossref_primary_10_1016_j_jaip_2019_02_025
crossref_primary_10_1016_j_jid_2024_01_005
crossref_primary_10_1016_j_therap_2021_08_001
crossref_primary_10_1136_bmjopen_2021_058205
crossref_primary_10_1001_jamadermatol_2020_2977
crossref_primary_10_3389_fped_2022_988674
crossref_primary_10_1177_17562848211002359
crossref_primary_10_1002_cncr_34944
crossref_primary_10_1093_aje_kwz071
crossref_primary_10_1016_j_pmedr_2023_102429
crossref_primary_10_1007_s10029_023_02885_x
crossref_primary_10_1093_ageing_afad165
crossref_primary_10_1186_s12913_025_12308_5
crossref_primary_10_1002_pds_5709
crossref_primary_10_1212_WNL_0000000000201027
crossref_primary_10_1016_j_rbmo_2023_02_004
crossref_primary_10_1371_journal_pone_0295336
crossref_primary_10_1111_bjh_18995
crossref_primary_10_1093_ofid_ofae349
crossref_primary_10_1007_s00520_019_05188_z
crossref_primary_10_2147_JAA_S376786
crossref_primary_10_3389_fmed_2021_802989
crossref_primary_10_1136_rmdopen_2023_003570
crossref_primary_10_1016_j_acvd_2024_11_001
crossref_primary_10_1016_j_amjcard_2023_07_075
crossref_primary_10_1017_S0266462324000291
crossref_primary_10_1016_j_annonc_2023_09_3106
crossref_primary_10_1186_s13690_020_00436_9
crossref_primary_10_1016_j_acvd_2024_10_322
crossref_primary_10_1016_j_acvd_2024_10_325
crossref_primary_10_1016_j_respe_2017_05_001
crossref_primary_10_1016_j_acvd_2024_10_324
crossref_primary_10_1016_j_respe_2021_02_002
crossref_primary_10_1080_03007995_2024_2421287
crossref_primary_10_1016_j_rcot_2023_02_002
crossref_primary_10_1245_s10434_024_15050_0
crossref_primary_10_1007_s40264_018_0668_9
crossref_primary_10_1016_j_ctarc_2021_100343
crossref_primary_10_1016_j_acvd_2023_12_008
crossref_primary_10_1016_j_vaccine_2024_06_007
crossref_primary_10_1016_j_toxac_2020_09_072
crossref_primary_10_1002_pds_4842
crossref_primary_10_1111_apt_18462
crossref_primary_10_1111_dom_15472
crossref_primary_10_1186_s12954_022_00702_9
crossref_primary_10_1212_WNL_0000000000007696
crossref_primary_10_1016_j_therap_2024_05_003
crossref_primary_10_1080_16078454_2024_2320610
crossref_primary_10_1111_bcp_14387
crossref_primary_10_1186_s12875_024_02328_1
crossref_primary_10_1002_jcph_2003
crossref_primary_10_1111_jdv_16566
crossref_primary_10_1212_WNL_0000000000006246
crossref_primary_10_1016_j_bulcan_2019_03_007
crossref_primary_10_1016_j_neuchi_2021_11_003
crossref_primary_10_1017_S0950268819000402
crossref_primary_10_1016_j_clinthera_2025_02_005
crossref_primary_10_3390_cancers12113453
crossref_primary_10_1002_pds_4870
crossref_primary_10_1002_pds_4635
crossref_primary_10_1016_j_jad_2020_05_071
crossref_primary_10_1186_s12879_017_2889_4
crossref_primary_10_31616_asj_2021_0213
crossref_primary_10_1002_mds_29205
crossref_primary_10_1016_j_rcot_2019_10_021
crossref_primary_10_1093_ckj_sfaa076
crossref_primary_10_1038_s41598_022_07984_w
crossref_primary_10_3390_ijerph18168780
crossref_primary_10_1007_s00330_025_11402_w
crossref_primary_10_1016_j_contraception_2023_109976
crossref_primary_10_1093_eurjpc_zwae194
crossref_primary_10_1111_acps_13582
crossref_primary_10_1007_s00701_024_06191_y
crossref_primary_10_1111_aos_14916
crossref_primary_10_1089_dia_2020_0112
crossref_primary_10_1111_dme_14457
crossref_primary_10_1136_rmdopen_2023_003762
crossref_primary_10_1177_13524585241291471
crossref_primary_10_1186_s12904_018_0327_z
crossref_primary_10_1016_j_jamda_2021_01_085
crossref_primary_10_1093_eurpub_ckaa137
crossref_primary_10_1016_j_ijcard_2021_11_056
crossref_primary_10_1093_rheumatology_keaa448
crossref_primary_10_3390_v16050792
crossref_primary_10_1016_j_ajpc_2020_100037
crossref_primary_10_1007_s00701_024_06093_z
crossref_primary_10_1038_s41598_020_68304_8
crossref_primary_10_1186_s12876_019_1031_z
crossref_primary_10_1016_j_vaccine_2022_06_071
crossref_primary_10_1093_rheumatology_keab522
crossref_primary_10_1016_j_envres_2024_118458
crossref_primary_10_1016_j_acvd_2024_12_002
crossref_primary_10_1016_j_soard_2020_04_022
crossref_primary_10_1007_s12603_019_1186_x
crossref_primary_10_1016_j_jaut_2022_102910
crossref_primary_10_1093_bjd_ljae454
crossref_primary_10_1136_rmdopen_2023_003531
crossref_primary_10_1007_s11060_023_04295_6
crossref_primary_10_1016_j_jcf_2024_03_001
crossref_primary_10_1016_j_ekir_2024_05_008
crossref_primary_10_1002_pds_4898
crossref_primary_10_1136_bmj_2021_066192
crossref_primary_10_1016_j_canep_2020_101689
crossref_primary_10_1016_j_ijcha_2021_100936
crossref_primary_10_1007_s00264_020_04492_2
crossref_primary_10_1186_s12882_020_1692_4
crossref_primary_10_1080_17512433_2022_2115356
crossref_primary_10_1136_oemed_2022_108656
crossref_primary_10_1016_j_respe_2017_06_001
crossref_primary_10_1080_20016689_2023_2270293
crossref_primary_10_1007_s13300_024_01577_8
crossref_primary_10_1055_s_0042_1743475
crossref_primary_10_1161_STROKEAHA_118_023495
crossref_primary_10_1007_s40265_023_01918_0
crossref_primary_10_1016_j_diabet_2024_101509
crossref_primary_10_1136_bmjopen_2017_018180
crossref_primary_10_1111_fcp_12444
crossref_primary_10_3390_cancers14112671
crossref_primary_10_1002_pds_5616
crossref_primary_10_1016_j_ejogrb_2024_03_014
crossref_primary_10_1093_ageing_afac053
Cites_doi 10.1016/j.nephro.2016.07.446
10.1002/pds.2244
10.1016/j.vaccine.2011.02.064
10.1002/pds.3613
10.1002/bjs.10557
10.1111/j.1475-5890.2016.12107
10.1016/j.healthpol.2016.01.007
10.1016/j.jclinepi.2004.10.012
10.1002/pds.3439
10.1097/MLR.0b013e31819c95aa
10.1016/j.respe.2015.12.015
10.1007/s10654-015-0096-4
10.1002/pds.1545
10.1016/j.respe.2013.01.039
10.1097/MLR.0000000000000471
10.1073/pnas.1510502113
10.1016/j.jval.2015.09.850
10.1161/JAHA.114.001402
10.1161/CIRCULATIONAHA.115.015710
10.1016/S0398-7620(06)76725-6
10.1016/j.respe.2016.11.003
10.1377/hlthaff.2014.0038
10.1136/jech-2013-202744
10.1186/1471-2474-13-103
10.1007/s00125-011-2429-5
10.1186/1471-2458-9-33
10.1016/j.dld.2016.02.022
10.3917/spub.150.0155
10.1007/s10654-013-9873-0
10.1097/MD.0000000000005314
10.1186/1471-2458-10-242
10.1002/pds.3828
10.1016/S1262-3636(07)70063-0
10.1016/j.respe.2012.04.007
10.1016/S0140-6736(16)00580-8
10.1093/pubmed/fdm065
10.3310/hta9200
10.3917/pos.411.0001
10.2515/therapie/2015027
10.1007/s00125-012-2538-9
10.1371/journal.pmed.1001885
ContentType Journal Article
Copyright 2017 Elsevier Masson SAS
Copyright © 2017 Elsevier Masson SAS. All rights reserved.
Copyright_xml – notice: 2017 Elsevier Masson SAS
– notice: Copyright © 2017 Elsevier Masson SAS. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.respe.2017.05.004
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
DocumentTitleAlternate L’utilité d’une base médico-administrative nationale pour guider la décision publique : du système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) vers le système national des données de santé (SNDS) en France
EndPage S167
ExternalDocumentID 28756037
10_1016_j_respe_2017_05_004
S0398762017304315
Genre Journal Article
Review
GroupedDBID .CO
08J
08T
0R~
4.4
457
53G
AABCJ
AAEDT
AAEDW
AALRI
AAXUO
AAYJJ
ABOCM
ACRLP
ADBBV
AENEX
AFNOS
AFTJW
AIDBO
AIKHN
AITUG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOOFG
DU5
EBS
EJD
FDB
FYGXN
HZ~
O9-
RIG
SEM
SES
AATTM
AAXKI
AAYWO
AAYXX
ACIEU
ACVFH
ADCNI
ADVLN
AEIPS
AEUPX
AFPUW
AFXIZ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
BNPGV
CITATION
EFJIC
SSH
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c359t-f8926ff5af961991f711d415e25238ac150af186aee4bfe5d986fd2b3655048a3
IEDL.DBID AIKHN
ISSN 0398-7620
IngestDate Fri Jul 11 10:50:33 EDT 2025
Wed Feb 19 02:01:05 EST 2025
Tue Jul 01 01:16:46 EDT 2025
Thu Apr 24 23:09:48 EDT 2025
Fri Feb 23 02:28:54 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords Assurance Maladie
Health insurance
Système national d’information en santé
French national health data system
Health care use
Consommation de soins
Épidémiologie
France
Epidemiology
Language English
License Copyright © 2017 Elsevier Masson SAS. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c359t-f8926ff5af961991f711d415e25238ac150af186aee4bfe5d986fd2b3655048a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0001-5698-9215
PMID 28756037
PQID 1924890488
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1924890488
pubmed_primary_28756037
crossref_citationtrail_10_1016_j_respe_2017_05_004
crossref_primary_10_1016_j_respe_2017_05_004
elsevier_sciencedirect_doi_10_1016_j_respe_2017_05_004
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate October 2017
2017-10-00
2017-Oct
20171001
PublicationDateYYYYMMDD 2017-10-01
PublicationDate_xml – month: 10
  year: 2017
  text: October 2017
PublicationDecade 2010
PublicationPlace France
PublicationPlace_xml – name: France
PublicationTitle Revue d'épidémiologie et de santé publique
PublicationTitleAlternate Rev Epidemiol Sante Publique
PublicationYear 2017
Publisher Elsevier Masson SAS
Publisher_xml – name: Elsevier Masson SAS
References Wallace, Shah, Dennen, Bleicher, Crown (bib0025) 2014; 33
Franc, Pierre (bib0305) 2016; 27
Chaignot, Weill, Ricordeau, Alla (bib0215) 2015; 70
(bib0135) 2016; 0267
Gastaldi-Ménager, Geoffard, de Lagasnerie (bib0290) 2016; 37
Estupiñán Romero, Baixauli Pérez, Bernal-Delgado (bib0050) 2014
Célant, Guillaume, Rochereau (bib0150) 2014
Fonds de financement de la protection complémentaire de la couverture universelle du risque maladie (bib0310) 2015; 1–56
Després, Dourgnon, Fantin, Jusot (bib0325) 2011; 170
Morrato, Elias, Gericke (bib0005) 2007; 29
Bannay, Chaignot, Blotière, Basson, Weill, Ricordeau (bib0245) 2016; 54
(bib0110) 2016; 0022
de Lagasnerie, Jusot, Wittwer, Ricci-Renaud, Gastaldi-Menager, Mazars (bib0295) 2015
Neumann, Weill, Ricordeau, Fagot, Alla, Allemand (bib0220) 2012; 55
Milea, Azmi, Reginald, Verpillat, Francois (bib0035) 2015; 3
Assemblée nationale. Projet de loi de financement de la Sécurité sociale pour 2016. 2015
Pigeot, Ahrens (bib0065) 2008; 17
Ricordeau, Weill, Vallier, Bourrel, Schwartz, Guilhot (bib0340) 2003; 29
Thereaux J, Lesuffleur T, Czernichow S, Paita M, Basdevant A, Msika S, et al. A poor long-term follow-up after bariatric surgery: a 5-year nationwide French cohort. 2017. [accepté BJS].
Couralet (bib0255) 2015
Caby, Eidelman (bib0270) 2015; 145
Gavrielov-Yusim, Friger (bib0020) 2014; 68
CNAMTS (bib0125) 2016
Allenbach, Pereira (bib0335) 2015; 27
Benchimol, Smeeth, Guttmann, Harron, Moher, Petersen (bib0185) 2015; 12
Zins, Goldberg, CONSTANCES team (bib0145) 2015; 30
Atramont, Rigault, Chevalier, Leblanc, Fagot-Campagna, Tuppin (bib0180) 2017; 65
Kimura, Matsushita, Yang, Choi, Park (bib0010) 2011; 20
Chevreul, Durand-Zaleski, Bahrami, Hernández-Quevedo, Mladovsky (bib0120) 2010; 12
Aguade, De Lagasnerie, Denis, Gastaldi-Menager, Fagot-Campagna, Gissot (bib0345) 2015; 18
Raftery, Roderick, Stevens (bib0075) 2005; 9
.
Andersen, Bergman, Choi, Gerhard, Huang, Jalbert (bib0040) 2013; 22
Tuppin, Cuerq, Torre, Couchoud, Fagot-Campagna (bib0210) 2017; 13
Trouessin, Allaert (bib0130) 1997; 43
Nay, Béjean, Benamouzig, Bergeron, Castel, Ventelou (bib0115) 2016; 387
Direction de la recherche, des études, de l’évaluation et des statistiques (DREES) (bib0260) 2016
Bouchet, Courtois, Le Guéhennec (bib0320) 2015
Charlton, Neville, Jordan, Pierini, Damase-Michel, Klungsøyr (bib0045) 2014; 23
Hercberg, Castetbon, Czernichow, Malon, Mejean, Kesse (bib0140) 2010; 10
Platt, Carnahan, Brown, Chrischilles, Curtis, Hennessy (bib0015) 2012; 21
Blin, Lassalle, Dureau-Pournin, Ambrosino, Bernard, Abouelfath (bib0250) 2012; 55
Renoux, Patenaude, Suissa (bib0230) 2014; 3
Smoyer-Tomic, Amato, Fernandes (bib0225) 2012; 13
Couillerot-Peyrondet, Sambuc, Sainsaulieu, Couchoud, Bongiovanni-Delarozière (bib0360) 2016
Rey, Jougla, Fouillet, Hémon (bib0165) 2009; 9
Kreis, Neubauer, Klora, Lange, Zeidler (bib0030) 2016; 120
Riley (bib0085) 2009; 47
Ricci (bib0300) 2011; 35
Bras, Loth (bib0100) 2013
Goldberg, Berr, Cases, Charpak, Danet, Desenclos (bib0095) 2012
Lardellier, Legal, Raynaud, Vidal (bib0315) 2012; 34
Haut Conseil pour l’avenir de l’Assurance Maladie (HCAAM). Rapport annuel 2013.2014
Tuppin, Samson, Colinot, Gastaldi-Menager, Fagot-Campagna, Gissot (bib0160) 2016; 64
Cour des Comptes (bib0275) 2016
CNAMTS (bib0175) 2015
Hripcsak, Ryan, Duke, Shah, Park, Huser (bib0060) 2016; 113
Païta, Rivière, Tala, Fagot-Campagna (bib0170) 2016; 46
(bib0370) 2016
Czernichow, Paita, Nocca, Msika, Basdevant, Millat (bib0195) 2016; 95
Goldberg (bib0070) 2006; 54
Bazelier, Eriksson, de Vries, Schmidt, Raitanen, Haukka (bib0055) 2015; 24
Fagot, Boutrelle, Ricordeau, Weill, Allemand (bib0365) 2011; 29
Direction de la recherche, des études, de l’évaluation et des statistiques (bib0105) 2015; 64
Ricci, Mezzarobba, Blotière, Polton (bib0350) 2013; 61
Maura, Blotière, Bouillon, Billionnet, Ricordeau, Alla (bib0200) 2015; 132
Blotière, Rudant, Barré, Racine, Weill, Peyrin-Biroulet (bib0190) 2016; 48
Ben Halima, Regaert (bib0155) 2013; 33
Chaignot, Weill, Blotiere, Ricordeau, Alla, Allemand (bib0205) 2013; S1
Thygesen, Ersbøll (bib0090) 2014; 29
Dessauce, Rudant, Expert, Barthelemy, Cadier (bib0235) 2016; 44
Schneeweiss, Avorn (bib0080) 2005; 58
Geay, de Lagasnerie (bib0280) 2013; 8
Dourgnon, Or, Sorasith (bib0355) 2013; 183
Ricci, Chantry, Detournay, Poutignat, Kusnik-Joinville, Raimond (bib0330) 2010; 41
Thygesen (10.1016/j.respe.2017.05.004_bib0090) 2014; 29
Cour des Comptes (10.1016/j.respe.2017.05.004_bib0275) 2016
Ricci (10.1016/j.respe.2017.05.004_bib0300) 2011; 35
Goldberg (10.1016/j.respe.2017.05.004_bib0095) 2012
Charlton (10.1016/j.respe.2017.05.004_bib0045) 2014; 23
Geay (10.1016/j.respe.2017.05.004_bib0280) 2013; 8
10.1016/j.respe.2017.05.004_bib0285
Couillerot-Peyrondet (10.1016/j.respe.2017.05.004_bib0360) 2016
Raftery (10.1016/j.respe.2017.05.004_bib0075) 2005; 9
(10.1016/j.respe.2017.05.004_bib0135) 2016; 0267
10.1016/j.respe.2017.05.004_bib0240
Gavrielov-Yusim (10.1016/j.respe.2017.05.004_bib0020) 2014; 68
Direction de la recherche, des études, de l’évaluation et des statistiques (10.1016/j.respe.2017.05.004_bib0105) 2015; 64
CNAMTS (10.1016/j.respe.2017.05.004_bib0125) 2016
CNAMTS (10.1016/j.respe.2017.05.004_bib0175) 2015
Blotière (10.1016/j.respe.2017.05.004_bib0190) 2016; 48
Dessauce (10.1016/j.respe.2017.05.004_bib0235) 2016; 44
Allenbach (10.1016/j.respe.2017.05.004_bib0335) 2015; 27
Renoux (10.1016/j.respe.2017.05.004_bib0230) 2014; 3
Bouchet (10.1016/j.respe.2017.05.004_bib0320) 2015
Milea (10.1016/j.respe.2017.05.004_bib0035) 2015; 3
Chevreul (10.1016/j.respe.2017.05.004_bib0120) 2010; 12
Fagot (10.1016/j.respe.2017.05.004_bib0365) 2011; 29
Hripcsak (10.1016/j.respe.2017.05.004_bib0060) 2016; 113
Caby (10.1016/j.respe.2017.05.004_bib0270) 2015; 145
Schneeweiss (10.1016/j.respe.2017.05.004_bib0080) 2005; 58
Direction de la recherche, des études, de l’évaluation et des statistiques (DREES) (10.1016/j.respe.2017.05.004_bib0260) 2016
de Lagasnerie (10.1016/j.respe.2017.05.004_bib0295) 2015
Fonds de financement de la protection complémentaire de la couverture universelle du risque maladie (10.1016/j.respe.2017.05.004_bib0310) 2015; 1–56
Kimura (10.1016/j.respe.2017.05.004_bib0010) 2011; 20
Hercberg (10.1016/j.respe.2017.05.004_bib0140) 2010; 10
Bras (10.1016/j.respe.2017.05.004_bib0100) 2013
Czernichow (10.1016/j.respe.2017.05.004_bib0195) 2016; 95
Bazelier (10.1016/j.respe.2017.05.004_bib0055) 2015; 24
Tuppin (10.1016/j.respe.2017.05.004_bib0160) 2016; 64
Franc (10.1016/j.respe.2017.05.004_bib0305) 2016; 27
(10.1016/j.respe.2017.05.004_bib0370) 2016
Chaignot (10.1016/j.respe.2017.05.004_bib0205) 2013; S1
Smoyer-Tomic (10.1016/j.respe.2017.05.004_bib0225) 2012; 13
Dourgnon (10.1016/j.respe.2017.05.004_bib0355) 2013; 183
Gastaldi-Ménager (10.1016/j.respe.2017.05.004_bib0290) 2016; 37
Platt (10.1016/j.respe.2017.05.004_bib0015) 2012; 21
Benchimol (10.1016/j.respe.2017.05.004_bib0185) 2015; 12
Morrato (10.1016/j.respe.2017.05.004_bib0005) 2007; 29
Zins (10.1016/j.respe.2017.05.004_bib0145) 2015; 30
Couralet (10.1016/j.respe.2017.05.004_bib0255) 2015
Tuppin (10.1016/j.respe.2017.05.004_bib0210) 2017; 13
Ricordeau (10.1016/j.respe.2017.05.004_bib0340) 2003; 29
Aguade (10.1016/j.respe.2017.05.004_bib0345) 2015; 18
Lardellier (10.1016/j.respe.2017.05.004_bib0315) 2012; 34
10.1016/j.respe.2017.05.004_bib0265
Kreis (10.1016/j.respe.2017.05.004_bib0030) 2016; 120
Goldberg (10.1016/j.respe.2017.05.004_bib0070) 2006; 54
Riley (10.1016/j.respe.2017.05.004_bib0085) 2009; 47
Wallace (10.1016/j.respe.2017.05.004_bib0025) 2014; 33
Pigeot (10.1016/j.respe.2017.05.004_bib0065) 2008; 17
Célant (10.1016/j.respe.2017.05.004_bib0150) 2014
Nay (10.1016/j.respe.2017.05.004_bib0115) 2016; 387
Trouessin (10.1016/j.respe.2017.05.004_bib0130) 1997; 43
Rey (10.1016/j.respe.2017.05.004_bib0165) 2009; 9
Païta (10.1016/j.respe.2017.05.004_bib0170) 2016; 46
Maura (10.1016/j.respe.2017.05.004_bib0200) 2015; 132
Ricci (10.1016/j.respe.2017.05.004_bib0350) 2013; 61
Ben Halima (10.1016/j.respe.2017.05.004_bib0155) 2013; 33
Andersen (10.1016/j.respe.2017.05.004_bib0040) 2013; 22
Blin (10.1016/j.respe.2017.05.004_bib0250) 2012; 55
Estupiñán Romero (10.1016/j.respe.2017.05.004_bib0050) 2014
Ricci (10.1016/j.respe.2017.05.004_bib0330) 2010; 41
(10.1016/j.respe.2017.05.004_bib0110) 2016; 0022
Atramont (10.1016/j.respe.2017.05.004_bib0180) 2017; 65
Neumann (10.1016/j.respe.2017.05.004_bib0220) 2012; 55
Bannay (10.1016/j.respe.2017.05.004_bib0245) 2016; 54
Després (10.1016/j.respe.2017.05.004_bib0325) 2011; 170
Chaignot (10.1016/j.respe.2017.05.004_bib0215) 2015; 70
References_xml – volume: 13
  start-page: 76
  year: 2017
  end-page: 86
  ident: bib0210
  article-title: Management of patients with end-stage renal disease prior to initiation of renal replacement therapy in 2013 in France
  publication-title: Nephrol Ther
– year: 2015
  ident: bib0320
  article-title: Aide complémentaire santé (ACS) : restes à charge et coût d’accès aux soins des bénéficiaires
  publication-title: 37
– volume: 387
  start-page: 2236
  year: 2016
  end-page: 2249
  ident: bib0115
  article-title: Achieving universal health coverage in France: policy reforms and the challenge of inequalities
  publication-title: Lancet
– volume: 145
  start-page: 1
  year: 2015
  end-page: 7
  ident: bib0270
  article-title: Quel avenir pour le dispositif de prise en charge des affections de longue durée (ALD) ?
  publication-title: Tresor-Eco
– volume: 65
  start-page: 221
  year: 2017
  end-page: 230
  ident: bib0180
  article-title: Caractéristiques, pathologies et mortalité des résidents en EHPAD admis au cours du premier trimestre 2013 en France
  publication-title: Rev Epidemiol Sante Publique
– volume: 48
  start-page: 620
  year: 2016
  end-page: 625
  ident: bib0190
  article-title: Conditions of prescription of anti-TNF agents in newly treated patients with inflammatory bowel disease in France (2011–2013)
  publication-title: Dig Liver Dis
– volume: 55
  start-page: 644
  year: 2012
  end-page: 653
  ident: bib0250
  article-title: Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database
  publication-title: Diabetologia
– volume: 13
  start-page: 103
  year: 2012
  ident: bib0225
  article-title: Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis
  publication-title: BMC Musculoskelet Disord
– volume: 27
  start-page: 1
  year: 2016
  end-page: 6
  ident: bib0305
  article-title: Restes à charges élevés : profils d’assurés et persistance dans le temps
  publication-title: IRDES Question Econ Sante
– start-page: 141
  year: 2015
  end-page: 169
  ident: bib0295
  article-title: Une analyse longitudinale (2008–2013) du reste à charge des ménages après remboursement par l’Assurance maladie obligatoire
  publication-title: Les dépenses de santé en 2014. Résultats des Comptes de la Santé. Collection Etudes et Statistiques
– volume: 29
  start-page: 551
  year: 2014
  end-page: 558
  ident: bib0090
  article-title: When the entire population is the sample: strengths and limitations in register-based epidemiology
  publication-title: Eur J Epidemiol
– volume: 120
  start-page: 213
  year: 2016
  end-page: 226
  ident: bib0030
  article-title: Status and perspectives of claims data analyses in Germany – A systematic review
  publication-title: Health Policy
– volume: 27
  start-page: S155
  year: 2015
  end-page: S165
  ident: bib0335
  article-title: Analysis of reimbursement of dialysis patients’ transport expenses in Lorraine
  publication-title: Sante Publique
– volume: 21
  start-page: 1
  year: 2012
  end-page: 8
  ident: bib0015
  article-title: The US Food and Drug Administration's Mini-Sentinel program: status and direction
  publication-title: Pharmacoepidemiol Drug Saf
– volume: 12
  start-page: e1001885
  year: 2015
  ident: bib0185
  article-title: The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement
  publication-title: PLoS Med
– volume: 132
  start-page: 1252
  year: 2015
  end-page: 1260
  ident: bib0200
  article-title: Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study
  publication-title: Circulation
– start-page: 128
  year: 2013
  ident: bib0100
  article-title: Rapport sur la gouvernance et l’utilisation des données de santé
– volume: 55
  start-page: 1953
  year: 2012
  end-page: 1962
  ident: bib0220
  article-title: Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
  publication-title: Diabetologia
– volume: 61
  start-page: 29
  year: 2013
  end-page: 36
  ident: bib0350
  article-title: Reimbursed health expenditures during the last year of life, in France, in the year 2008
  publication-title: Rev Epidemiol Sante Publique
– year: 2012
  ident: bib0095
  article-title: Mieux utiliser les bases de données nationales pour la santé publique et la recherche
– reference: Assemblée nationale. Projet de loi de financement de la Sécurité sociale pour 2016. 2015
– volume: 41
  start-page: 1
  year: 2010
  end-page: 10
  ident: bib0330
  article-title: Analyse économique des soins des personnes traitées pour diabète (études entre 2001 et 2007)
  publication-title: Prat Organ Soins
– volume: 3
  year: 2015
  ident: bib0035
  article-title: A review of accessibility of administrative healthcare databases in the Asia-Pacific region
  publication-title: J Mark Access Health Policy
– volume: 12
  start-page: 1
  year: 2010
  end-page: 291
  ident: bib0120
  article-title: France: health system review
  publication-title: Health Syst Transit
– start-page: 0267
  year: 2016
  ident: bib0370
  article-title: Décret n
  publication-title: JORF
– start-page: 207
  year: 2016
  end-page: 244
  ident: bib0275
  article-title: Rapport sur l’application des lois de financement de la sécurité sociale : la prise en charge des affections de longue durée : une dynamique non maîtrisée, une gestion médicalisée de la dépense à mettre en œuvre
  publication-title: Cour Comptes
– volume: 20
  start-page: 1237
  year: 2011
  end-page: 1245
  ident: bib0010
  article-title: Pharmacovigilance systems and databases in Korea, Japan, and Taiwan
  publication-title: Pharmacoepidemiol Drug Saf
– reference: Thereaux J, Lesuffleur T, Czernichow S, Paita M, Basdevant A, Msika S, et al. A poor long-term follow-up after bariatric surgery: a 5-year nationwide French cohort. 2017. [accepté BJS].
– start-page: 272
  year: 2015
  ident: bib0175
  article-title: Étude des algorithmes de définition des pathologies dans le SNIIRAM
– volume: 54
  start-page: 297
  year: 2006
  end-page: 303
  ident: bib0070
  article-title: Administrative databases: could they be useful for epidemiology?
  publication-title: Rev Epidemiol Sante Publique
– volume: 22
  start-page: 700
  year: 2013
  end-page: 704
  ident: bib0040
  article-title: The Asian Pharmacoepidemiology Network (AsPEN): promoting multinational collaboration for pharmacoepidemiologic research in Asia
  publication-title: Pharmacoepidemiol Drug Saf
– volume: 10
  start-page: 242
  year: 2010
  end-page: 246
  ident: bib0140
  article-title: The NutriNet-Sante Study: a web-based prospective study on the relationship between nutrition and health and determinants of dietary patterns and nutritional status
  publication-title: BMC Public Health
– start-page: 302
  year: 2014
  ident: bib0150
  article-title: Enquête sur la santé et la protection sociale 2012
– volume: 0267
  year: 2016
  ident: bib0135
  article-title: Décret n
  publication-title: JORF
– volume: 64
  start-page: 1
  year: 2015
  end-page: 103
  ident: bib0105
  article-title: Données de santé : anonymat et risque de ré-identification
  publication-title: DREES Solidarite Sante
– volume: 95
  start-page: e5314
  year: 2016
  ident: bib0195
  article-title: Current challenges in providing bariatric surgery in France: a nationwide study
  publication-title: Medicine
– volume: 29
  start-page: 3610
  year: 2011
  end-page: 3616
  ident: bib0365
  article-title: HPV vaccination in France: uptake, costs and issues for the National Health Insurance
  publication-title: Vaccine
– volume: 29
  start-page: 463
  year: 2007
  end-page: 471
  ident: bib0005
  article-title: Using population-based routine data for evidence-based health policy decisions: lessons from three examples of setting and evaluating national health policy in Australia, the UK and the USA
  publication-title: J Public Health
– volume: 1–56
  year: 2015
  ident: bib0310
  article-title: La dépense de CMU complémentaire par bénéficiaire 2013–2014
  publication-title: Fonds CMU
– volume: 9
  start-page: 33
  year: 2009
  ident: bib0165
  article-title: Ecological association between a deprivation index and mortality in France over the period 1997–2001: variations with spatial scale, degree of urbanicity, age, gender and cause of death
  publication-title: BMC Public Health
– volume: 47
  start-page: S51
  year: 2009
  end-page: S55
  ident: bib0085
  article-title: Administrative and claims records as sources of health care cost data
  publication-title: Med Care
– volume: S1
  start-page: S16
  year: 2013
  ident: bib0205
  article-title: Intérêt de l’identifiant bénéficiaire anonyme unique vie entière dans le SNIIRAM et de son utilisation après chaînage dans le PMSI
  publication-title: Rev Epidemiol Sante Publique
– year: 2015
  ident: bib0255
  article-title: Évaluation médico-économique du programme Sophia
– year: 2016
  ident: bib0260
  article-title: Les dépenses de santé en 2015. Résultats des comptes de la santé
– volume: 33
  start-page: 1187
  year: 2014
  end-page: 1194
  ident: bib0025
  article-title: Optum Labs: building a novel node in the learning health care system
  publication-title: Health Aff (Millwood)
– volume: 64
  start-page: 67
  year: 2016
  end-page: 78
  ident: bib0160
  article-title: Health care use by free complementary health insurance coverage beneficiaries in France in 2012
  publication-title: Rev Epidemiol Sante Publique
– volume: 8
  start-page: 1
  year: 2013
  end-page: 39
  ident: bib0280
  article-title: Projection des dépenses de santé à l’horizon 2060, le modèle PROMEDE
  publication-title: Cah Doc Travail Tresor
– volume: 18
  start-page: A387
  year: 2015
  end-page: A388
  ident: bib0345
  article-title: Estimating the burden of diabetes to the French national health insurance
  publication-title: Value Health
– volume: 34
  start-page: 1
  year: 2012
  end-page: 59
  ident: bib0315
  article-title: Dépenses de santé et restes à charge des ménages : le modèle de microsimulation Omar
  publication-title: DREES
– volume: 43
  start-page: 196
  year: 1997
  end-page: 200
  ident: bib0130
  article-title: FOIN: a nominative information occultation function
  publication-title: Stud Health Technol Inform
– volume: 30
  start-page: 1317
  year: 2015
  end-page: 1328
  ident: bib0145
  article-title: The French CONSTANCES population-based cohort: design, inclusion and follow-up
  publication-title: Eur J Epidemiol
– volume: 58
  start-page: 323
  year: 2005
  end-page: 337
  ident: bib0080
  article-title: A review of uses of health care utilization databases for epidemiologic research on therapeutics
  publication-title: J Clin Epidemiol
– volume: 29
  start-page: 497
  year: 2003
  end-page: 504
  ident: bib0340
  article-title: The prevalence and cost of diabetes in metropolitan France: what trends between 1998 and 2000?
  publication-title: Diabetes Metab
– volume: 0022
  year: 2016
  ident: bib0110
  article-title: Loi n
  publication-title: JORF
– volume: 23
  start-page: 586
  year: 2014
  end-page: 594
  ident: bib0045
  article-title: Healthcare databases in Europe for studying medicine use and safety during pregnancy
  publication-title: Pharmacoepidemiol Drug Saf
– year: 2014
  ident: bib0050
  article-title: Handbook on methodology: ECHO information system quality report
– volume: 183
  start-page: 1
  year: 2013
  end-page: 6
  ident: bib0355
  article-title: L’impact du dispositif des affections de longue durée (ALD) sur les inégalités de recours aux soins ambulatoires entre 1998 et 2008
  publication-title: IRDES Questions Econ Sante
– year: 2016
  ident: bib0360
  article-title: A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events
  publication-title: Eur J Health Econ
– volume: 17
  start-page: 215
  year: 2008
  end-page: 223
  ident: bib0065
  article-title: Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations
  publication-title: Pharmacoepidemiol Drug Saf
– volume: 54
  start-page: 188
  year: 2016
  end-page: 194
  ident: bib0245
  article-title: The best use of the Charlson comorbidity index with electronic health care database to predict mortality
  publication-title: Med Care
– volume: 37
  start-page: 421
  year: 2016
  ident: bib0290
  article-title: Medical spending in France: concentration, persistence and evolution before death
  publication-title: Fiscal Stud
– volume: 170
  start-page: 1
  year: 2011
  end-page: 6
  ident: bib0325
  article-title: Le renoncement aux soins pour raisons financières : une approche économétrique
  publication-title: Question Econ Sante
– volume: 113
  start-page: 7329
  year: 2016
  end-page: 7336
  ident: bib0060
  article-title: Characterizing treatment pathways at scale using the OHDSI network
  publication-title: Proc Natl Acad Sci U S A
– volume: 3
  start-page: e001402
  year: 2014
  ident: bib0230
  article-title: Incidence, mortality, and sex differences of non-valvular atrial fibrillation: a population-based study
  publication-title: J Am Heart Assoc
– start-page: 172
  year: 2016
  ident: bib0125
  article-title: Améliorer la qualité du système de santé et maîtriser les dépenses. Propositions de l’Assurance Maladie pour 2017. Rapport au ministre chargé de la Sécurité sociale et au Parlement sur l’évolution des charges et des produits de l’Assurance Maladie au titre de 2017 (loi du 13 août 2004)
– volume: 33
  start-page: 46
  year: 2013
  end-page: 55
  ident: bib0155
  article-title: Duration of sick leave, income and health insurance: evidence from French linked employer–employee data
  publication-title: Econ Bull
– volume: 44
  start-page: 1
  year: 2016
  end-page: 7
  ident: bib0235
  article-title: Les antiviraux à action directe (AAD) dans le traitement de l’hépatite C : retour sur 18 mois de prise en charge par l’Assurance Maladie
  publication-title: Point Repere
– reference: .
– volume: 68
  start-page: 283
  year: 2014
  end-page: 287
  ident: bib0020
  article-title: Use of administrative medical databases in population-based research
  publication-title: J Epidemiol Community Health
– volume: 9
  start-page: 1
  year: 2005
  end-page: 92
  ident: bib0075
  article-title: Potential use of routine databases in health technology assessment
  publication-title: Health Technol Assess
– reference: Haut Conseil pour l’avenir de l’Assurance Maladie (HCAAM). Rapport annuel 2013.2014
– volume: 70
  start-page: 443
  year: 2015
  end-page: 453
  ident: bib0215
  article-title: Use in France of baclofen for alcohol dependence from 2007 to 2013: cohort study based on the databases SNIIRAM and PMSI
  publication-title: Therapie
– volume: 35
  start-page: 1
  year: 2011
  end-page: 11
  ident: bib0300
  article-title: Reste à charge des personnes bénéficiant de la CMU-C en 2010
  publication-title: Point Repere
– volume: 24
  start-page: 897
  year: 2015
  end-page: 905
  ident: bib0055
  article-title: Data management and data analysis techniques in pharmacoepidemiological studies using a pre-planned multi-database approach: a systematic literature review
  publication-title: Pharmacoepidemiol Drug Saf
– volume: 46
  start-page: 1
  year: 2016
  end-page: 8
  ident: bib0170
  article-title: Les bénéficiaires du dispositif des affections de longue durée en 2014 et les évolutions depuis 2005
  publication-title: Points Repere
– volume: 13
  start-page: 76
  year: 2017
  ident: 10.1016/j.respe.2017.05.004_bib0210
  article-title: Management of patients with end-stage renal disease prior to initiation of renal replacement therapy in 2013 in France
  publication-title: Nephrol Ther
  doi: 10.1016/j.nephro.2016.07.446
– year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0360
  article-title: A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events
  publication-title: Eur J Health Econ
– volume: 20
  start-page: 1237
  year: 2011
  ident: 10.1016/j.respe.2017.05.004_bib0010
  article-title: Pharmacovigilance systems and databases in Korea, Japan, and Taiwan
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.2244
– volume: 29
  start-page: 3610
  year: 2011
  ident: 10.1016/j.respe.2017.05.004_bib0365
  article-title: HPV vaccination in France: uptake, costs and issues for the National Health Insurance
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2011.02.064
– volume: 23
  start-page: 586
  year: 2014
  ident: 10.1016/j.respe.2017.05.004_bib0045
  article-title: Healthcare databases in Europe for studying medicine use and safety during pregnancy
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.3613
– ident: 10.1016/j.respe.2017.05.004_bib0240
  doi: 10.1002/bjs.10557
– start-page: 207
  year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0275
  article-title: Rapport sur l’application des lois de financement de la sécurité sociale : la prise en charge des affections de longue durée : une dynamique non maîtrisée, une gestion médicalisée de la dépense à mettre en œuvre
  publication-title: Cour Comptes
– volume: 37
  start-page: 421
  year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0290
  article-title: Medical spending in France: concentration, persistence and evolution before death
  publication-title: Fiscal Stud
  doi: 10.1111/j.1475-5890.2016.12107
– volume: 120
  start-page: 213
  year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0030
  article-title: Status and perspectives of claims data analyses in Germany – A systematic review
  publication-title: Health Policy
  doi: 10.1016/j.healthpol.2016.01.007
– volume: 1–56
  year: 2015
  ident: 10.1016/j.respe.2017.05.004_bib0310
  article-title: La dépense de CMU complémentaire par bénéficiaire 2013–2014
  publication-title: Fonds CMU
– volume: 35
  start-page: 1
  year: 2011
  ident: 10.1016/j.respe.2017.05.004_bib0300
  article-title: Reste à charge des personnes bénéficiant de la CMU-C en 2010
  publication-title: Point Repere
– volume: 58
  start-page: 323
  year: 2005
  ident: 10.1016/j.respe.2017.05.004_bib0080
  article-title: A review of uses of health care utilization databases for epidemiologic research on therapeutics
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2004.10.012
– volume: 22
  start-page: 700
  year: 2013
  ident: 10.1016/j.respe.2017.05.004_bib0040
  article-title: The Asian Pharmacoepidemiology Network (AsPEN): promoting multinational collaboration for pharmacoepidemiologic research in Asia
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.3439
– volume: 47
  start-page: S51
  issue: Suppl. 1
  year: 2009
  ident: 10.1016/j.respe.2017.05.004_bib0085
  article-title: Administrative and claims records as sources of health care cost data
  publication-title: Med Care
  doi: 10.1097/MLR.0b013e31819c95aa
– volume: 64
  start-page: 67
  year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0160
  article-title: Health care use by free complementary health insurance coverage beneficiaries in France in 2012
  publication-title: Rev Epidemiol Sante Publique
  doi: 10.1016/j.respe.2015.12.015
– year: 2014
  ident: 10.1016/j.respe.2017.05.004_bib0050
– volume: 30
  start-page: 1317
  year: 2015
  ident: 10.1016/j.respe.2017.05.004_bib0145
  article-title: The French CONSTANCES population-based cohort: design, inclusion and follow-up
  publication-title: Eur J Epidemiol
  doi: 10.1007/s10654-015-0096-4
– volume: 17
  start-page: 215
  year: 2008
  ident: 10.1016/j.respe.2017.05.004_bib0065
  article-title: Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.1545
– volume: S1
  start-page: S16
  year: 2013
  ident: 10.1016/j.respe.2017.05.004_bib0205
  article-title: Intérêt de l’identifiant bénéficiaire anonyme unique vie entière dans le SNIIRAM et de son utilisation après chaînage dans le PMSI
  publication-title: Rev Epidemiol Sante Publique
  doi: 10.1016/j.respe.2013.01.039
– volume: 46
  start-page: 1
  year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0170
  article-title: Les bénéficiaires du dispositif des affections de longue durée en 2014 et les évolutions depuis 2005
  publication-title: Points Repere
– ident: 10.1016/j.respe.2017.05.004_bib0285
– volume: 54
  start-page: 188
  year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0245
  article-title: The best use of the Charlson comorbidity index with electronic health care database to predict mortality
  publication-title: Med Care
  doi: 10.1097/MLR.0000000000000471
– volume: 113
  start-page: 7329
  year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0060
  article-title: Characterizing treatment pathways at scale using the OHDSI network
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1510502113
– volume: 18
  start-page: A387
  year: 2015
  ident: 10.1016/j.respe.2017.05.004_bib0345
  article-title: Estimating the burden of diabetes to the French national health insurance
  publication-title: Value Health
  doi: 10.1016/j.jval.2015.09.850
– volume: 0022
  year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0110
  article-title: Loi no 2016-41 du 26 janvier 2016 de modernisation de notre système de santé
  publication-title: JORF
– year: 2015
  ident: 10.1016/j.respe.2017.05.004_bib0320
  article-title: Aide complémentaire santé (ACS) : restes à charge et coût d’accès aux soins des bénéficiaires
– volume: 3
  start-page: e001402
  year: 2014
  ident: 10.1016/j.respe.2017.05.004_bib0230
  article-title: Incidence, mortality, and sex differences of non-valvular atrial fibrillation: a population-based study
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.114.001402
– year: 2015
  ident: 10.1016/j.respe.2017.05.004_bib0255
– volume: 8
  start-page: 1
  year: 2013
  ident: 10.1016/j.respe.2017.05.004_bib0280
  article-title: Projection des dépenses de santé à l’horizon 2060, le modèle PROMEDE
  publication-title: Cah Doc Travail Tresor
– volume: 170
  start-page: 1
  year: 2011
  ident: 10.1016/j.respe.2017.05.004_bib0325
  article-title: Le renoncement aux soins pour raisons financières : une approche économétrique
  publication-title: Question Econ Sante
– volume: 132
  start-page: 1252
  year: 2015
  ident: 10.1016/j.respe.2017.05.004_bib0200
  article-title: Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.115.015710
– volume: 54
  start-page: 297
  year: 2006
  ident: 10.1016/j.respe.2017.05.004_bib0070
  article-title: Administrative databases: could they be useful for epidemiology?
  publication-title: Rev Epidemiol Sante Publique
  doi: 10.1016/S0398-7620(06)76725-6
– year: 2012
  ident: 10.1016/j.respe.2017.05.004_bib0095
– start-page: 172
  year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0125
– volume: 65
  start-page: 221
  year: 2017
  ident: 10.1016/j.respe.2017.05.004_bib0180
  article-title: Caractéristiques, pathologies et mortalité des résidents en EHPAD admis au cours du premier trimestre 2013 en France
  publication-title: Rev Epidemiol Sante Publique
  doi: 10.1016/j.respe.2016.11.003
– start-page: 128
  year: 2013
  ident: 10.1016/j.respe.2017.05.004_bib0100
– start-page: 272
  year: 2015
  ident: 10.1016/j.respe.2017.05.004_bib0175
– volume: 33
  start-page: 1187
  year: 2014
  ident: 10.1016/j.respe.2017.05.004_bib0025
  article-title: Optum Labs: building a novel node in the learning health care system
  publication-title: Health Aff (Millwood)
  doi: 10.1377/hlthaff.2014.0038
– volume: 68
  start-page: 283
  year: 2014
  ident: 10.1016/j.respe.2017.05.004_bib0020
  article-title: Use of administrative medical databases in population-based research
  publication-title: J Epidemiol Community Health
  doi: 10.1136/jech-2013-202744
– volume: 27
  start-page: 1
  year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0305
  article-title: Restes à charges élevés : profils d’assurés et persistance dans le temps
  publication-title: IRDES Question Econ Sante
– ident: 10.1016/j.respe.2017.05.004_bib0265
– start-page: 302
  year: 2014
  ident: 10.1016/j.respe.2017.05.004_bib0150
– volume: 13
  start-page: 103
  year: 2012
  ident: 10.1016/j.respe.2017.05.004_bib0225
  article-title: Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis
  publication-title: BMC Musculoskelet Disord
  doi: 10.1186/1471-2474-13-103
– volume: 44
  start-page: 1
  year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0235
  article-title: Les antiviraux à action directe (AAD) dans le traitement de l’hépatite C : retour sur 18 mois de prise en charge par l’Assurance Maladie
  publication-title: Point Repere
– start-page: 0267
  year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0370
  article-title: Décret no 2016-1537 du 16 novembre 2016 relatif aux recherches impliquant la personne humaine
  publication-title: JORF
– volume: 55
  start-page: 644
  year: 2012
  ident: 10.1016/j.respe.2017.05.004_bib0250
  article-title: Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database
  publication-title: Diabetologia
  doi: 10.1007/s00125-011-2429-5
– volume: 33
  start-page: 46
  year: 2013
  ident: 10.1016/j.respe.2017.05.004_bib0155
  article-title: Duration of sick leave, income and health insurance: evidence from French linked employer–employee data
  publication-title: Econ Bull
– volume: 9
  start-page: 33
  year: 2009
  ident: 10.1016/j.respe.2017.05.004_bib0165
  article-title: Ecological association between a deprivation index and mortality in France over the period 1997–2001: variations with spatial scale, degree of urbanicity, age, gender and cause of death
  publication-title: BMC Public Health
  doi: 10.1186/1471-2458-9-33
– volume: 48
  start-page: 620
  year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0190
  article-title: Conditions of prescription of anti-TNF agents in newly treated patients with inflammatory bowel disease in France (2011–2013)
  publication-title: Dig Liver Dis
  doi: 10.1016/j.dld.2016.02.022
– volume: 27
  start-page: S155
  issue: 1 Suppl.
  year: 2015
  ident: 10.1016/j.respe.2017.05.004_bib0335
  article-title: Analysis of reimbursement of dialysis patients’ transport expenses in Lorraine
  publication-title: Sante Publique
  doi: 10.3917/spub.150.0155
– volume: 0267
  year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0135
  article-title: Décret no 2016-1871 du modifiant le décret no 2005-1309 du 20 octobre 2005 modifié pris pour l’application de la loi no 79-17 du 6 janvier 1978 relative à l’informatique, aux fichiers et aux libertés
  publication-title: JORF
– volume: 29
  start-page: 551
  year: 2014
  ident: 10.1016/j.respe.2017.05.004_bib0090
  article-title: When the entire population is the sample: strengths and limitations in register-based epidemiology
  publication-title: Eur J Epidemiol
  doi: 10.1007/s10654-013-9873-0
– volume: 95
  start-page: e5314
  year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0195
  article-title: Current challenges in providing bariatric surgery in France: a nationwide study
  publication-title: Medicine
  doi: 10.1097/MD.0000000000005314
– volume: 12
  start-page: 1
  year: 2010
  ident: 10.1016/j.respe.2017.05.004_bib0120
  article-title: France: health system review
  publication-title: Health Syst Transit
– volume: 145
  start-page: 1
  year: 2015
  ident: 10.1016/j.respe.2017.05.004_bib0270
  article-title: Quel avenir pour le dispositif de prise en charge des affections de longue durée (ALD) ?
  publication-title: Tresor-Eco
– volume: 43
  start-page: 196
  year: 1997
  ident: 10.1016/j.respe.2017.05.004_bib0130
  article-title: FOIN: a nominative information occultation function
  publication-title: Stud Health Technol Inform
– volume: 10
  start-page: 242
  year: 2010
  ident: 10.1016/j.respe.2017.05.004_bib0140
  article-title: The NutriNet-Sante Study: a web-based prospective study on the relationship between nutrition and health and determinants of dietary patterns and nutritional status
  publication-title: BMC Public Health
  doi: 10.1186/1471-2458-10-242
– volume: 24
  start-page: 897
  year: 2015
  ident: 10.1016/j.respe.2017.05.004_bib0055
  article-title: Data management and data analysis techniques in pharmacoepidemiological studies using a pre-planned multi-database approach: a systematic literature review
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.3828
– volume: 183
  start-page: 1
  year: 2013
  ident: 10.1016/j.respe.2017.05.004_bib0355
  article-title: L’impact du dispositif des affections de longue durée (ALD) sur les inégalités de recours aux soins ambulatoires entre 1998 et 2008
  publication-title: IRDES Questions Econ Sante
– volume: 3
  year: 2015
  ident: 10.1016/j.respe.2017.05.004_bib0035
  article-title: A review of accessibility of administrative healthcare databases in the Asia-Pacific region
  publication-title: J Mark Access Health Policy
– volume: 29
  start-page: 497
  year: 2003
  ident: 10.1016/j.respe.2017.05.004_bib0340
  article-title: The prevalence and cost of diabetes in metropolitan France: what trends between 1998 and 2000?
  publication-title: Diabetes Metab
  doi: 10.1016/S1262-3636(07)70063-0
– start-page: 141
  year: 2015
  ident: 10.1016/j.respe.2017.05.004_bib0295
  article-title: Une analyse longitudinale (2008–2013) du reste à charge des ménages après remboursement par l’Assurance maladie obligatoire
– volume: 61
  start-page: 29
  year: 2013
  ident: 10.1016/j.respe.2017.05.004_bib0350
  article-title: Reimbursed health expenditures during the last year of life, in France, in the year 2008
  publication-title: Rev Epidemiol Sante Publique
  doi: 10.1016/j.respe.2012.04.007
– volume: 21
  start-page: 1
  issue: Suppl. 1
  year: 2012
  ident: 10.1016/j.respe.2017.05.004_bib0015
  article-title: The US Food and Drug Administration's Mini-Sentinel program: status and direction
  publication-title: Pharmacoepidemiol Drug Saf
– volume: 34
  start-page: 1
  year: 2012
  ident: 10.1016/j.respe.2017.05.004_bib0315
  article-title: Dépenses de santé et restes à charge des ménages : le modèle de microsimulation Omar
  publication-title: DREES
– volume: 387
  start-page: 2236
  year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0115
  article-title: Achieving universal health coverage in France: policy reforms and the challenge of inequalities
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)00580-8
– year: 2016
  ident: 10.1016/j.respe.2017.05.004_bib0260
– volume: 29
  start-page: 463
  year: 2007
  ident: 10.1016/j.respe.2017.05.004_bib0005
  article-title: Using population-based routine data for evidence-based health policy decisions: lessons from three examples of setting and evaluating national health policy in Australia, the UK and the USA
  publication-title: J Public Health
  doi: 10.1093/pubmed/fdm065
– volume: 9
  start-page: 1
  year: 2005
  ident: 10.1016/j.respe.2017.05.004_bib0075
  article-title: Potential use of routine databases in health technology assessment
  publication-title: Health Technol Assess
  doi: 10.3310/hta9200
– volume: 41
  start-page: 1
  year: 2010
  ident: 10.1016/j.respe.2017.05.004_bib0330
  article-title: Analyse économique des soins des personnes traitées pour diabète (études entre 2001 et 2007)
  publication-title: Prat Organ Soins
  doi: 10.3917/pos.411.0001
– volume: 64
  start-page: 1
  year: 2015
  ident: 10.1016/j.respe.2017.05.004_bib0105
  article-title: Données de santé : anonymat et risque de ré-identification
  publication-title: DREES Solidarite Sante
– volume: 70
  start-page: 443
  year: 2015
  ident: 10.1016/j.respe.2017.05.004_bib0215
  article-title: Use in France of baclofen for alcohol dependence from 2007 to 2013: cohort study based on the databases SNIIRAM and PMSI
  publication-title: Therapie
  doi: 10.2515/therapie/2015027
– volume: 55
  start-page: 1953
  year: 2012
  ident: 10.1016/j.respe.2017.05.004_bib0220
  article-title: Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
  publication-title: Diabetologia
  doi: 10.1007/s00125-012-2538-9
– volume: 12
  start-page: e1001885
  year: 2015
  ident: 10.1016/j.respe.2017.05.004_bib0185
  article-title: The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1001885
SSID ssj0002747
Score 2.6111033
SecondaryResourceType review_article
Snippet In 1999, French legislators asked health insurance funds to develop a système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) [national...
In 1999, French legislators asked health insurance funds to develop a système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) [national...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage S149
SubjectTerms Assurance Maladie
Consommation de soins
Databases, Factual - standards
Decision Making
Epidemiology
France
French national health data system
Health care use
Health insurance
Humans
Medical Records Systems, Computerized - organization & administration
Medical Records Systems, Computerized - standards
National Health Programs - organization & administration
National Health Programs - standards
Public Health Administration - standards
Public Health Practice - standards
Système national d’information en santé
Épidémiologie
Title Value of a national administrative database to guide public decisions: From the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France
URI https://dx.doi.org/10.1016/j.respe.2017.05.004
https://www.ncbi.nlm.nih.gov/pubmed/28756037
https://www.proquest.com/docview/1924890488
Volume 65
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NjtMwELaW3QsSQst_WVgZiQMrEbVJGifmVhWqFmiFtizam-X4Z1XUTaq24cxr8Ab0Ofom8CLMxE4Bid0DpyhRxo4y4_E39vgbQp6nPFcqt2GgWZoGXZWFQZanPEi46mhwmWlc7-CPJ2x41n17npzvkX5zFgbTKr3vdz699tb-Sdv_zfZiNmtPOzHHoQwmFSNDTHKDHEQxZ2DaB73Ru-Fk55Ax8Ko3E5A6EwQa8qE6zQuC2gXSZYaOwdMXbPvHBHUVAK0nosEhue0RJO25j7xD9kxxl9xyy2_UnSq6R35-kvPK0NJSSZv1Pir_IMr9Yigmh-IkRtclvahm2lDHeU21r7uzekUHy_KSAkakyPi8_X5pfremf3z95mlX8QlF4onlcru5wEMl0Aadwwug_QpLdxg6lnPMLqMvppPR6LQ3PsFur2gZ5cui2G5cQyvQ_naDkq-nJ9APrauBmPvkbPDmY38Y-HoOgYoTvg5sxiNmbSItZ5hxZdMw1AAgTATRcCYVYFNpw4xJY7q5NYnmGbM6ymMGYVQ3k_EDsl-UhXlEqO4kSlseaiYBUoU5h6vOAf4oq0IrbYtEjRKF8mTnWHNjLpqsts-i1rxAzYtOIkDzLfJyJ7RwXB_Xv84a6xB_mayA2eh6wWeNLQkYzLhDIwtTViuB0XDG0am2yENnZLsvgdAW0GmcPv7fbo_ITbxzmYhPyP56WZmngKjW-TGMmP7p-w_HfuT8Ak0QKPI
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELaW7gEkhHhTnoPEgZWI2jTNw9yqhapltz3QXbQ3y_FjVdRNqj448zf4B_R39J_AH2EmdgpI7B44RUoydpQZj7-xx98w9irluVK5DQOdpGnQVVkYZHnKg5irtkaXmUbVDv5onAxOux_O4rM9dlifhaG0Su_7nU-vvLW_0_J_szWfTluTdsRpKKNJRcQQE19j-8ROFTfYfm94NBjvHDIFXtVmAlFnokBNPlSleWFQOye6zNAxePqCbf-YoC4DoNVE1L_NbnkECT33kXfYninusptu-Q3cqaJ77OcnOVsbKC1IqNf7QP5BlPvFACWH0iQGqxLO11NtwHFeg_Z1d5Zvob8oLwAxIhDj8_b7hfndmv7x9ZunXaU7QMQTi8V2c06HSrANmOELqP01le4wMJIzyi6D15PxcPixNzqgbi9pmeTLothuXENL1P52Q5LvJgfYD1TVQMx9dtp_f3I4CHw9h0BFMV8FNuOdxNpYWp5QxpVNw1AjgDAdjIYzqRCbShtmiTSmm1sTa54lVnfyKMEwqpvJ6AFrFGVhHjHQ7Vhpy0OdSIRUYc7xqnOEP8qq0ErbZJ1aiUJ5snOquTETdVbbZ1FpXpDmRTsWqPkme7MTmjuuj6tfT2rrEH-ZrMDZ6GrBl7UtCRzMtEMjC1Oul4Ki4YyTU22yh87Idl-CoS2i0yh9_L_dvmDXByejY3E8HB89YTfoictKfMoaq8XaPEN0tcqf-9HzC_gCKkM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Value+of+a+national+administrative+database+to+guide+public+decisions%3A+From+the+syst%C3%A8me+national+d%27information+interr%C3%A9gimes+de+l%27Assurance+Maladie+%28SNIIRAM%29+to+the+syst%C3%A8me+national+des+donn%C3%A9es+de+sant%C3%A9+%28SNDS%29+in+France&rft.jtitle=Revue+d%27%C3%A9pid%C3%A9miologie+et+de+sant%C3%A9+publique&rft.au=Tuppin%2C+P&rft.au=Rudant%2C+J&rft.au=Constantinou%2C+P&rft.au=Gastaldi-M%C3%A9nager%2C+C&rft.date=2017-10-01&rft.issn=0398-7620&rft.volume=65+Suppl+4&rft.spage=S149&rft_id=info:doi/10.1016%2Fj.respe.2017.05.004&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0398-7620&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0398-7620&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0398-7620&client=summon